Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Sees Significant Decrease in Short Interest
Fulcrum Therapeutics, Inc. (NASDAQ:FULC - Get Free Report) saw a large decline in short interest in December. As of December 15th, there was short interest totaling 2,994,328 shares, a decline of...